BLT 0.00% 2.6¢ benitec biopharma limited

breaking news, page-3

  1. 3,083 Posts.
    lightbulb Created with Sketch. 46
    ASX/Media Release

    GREAT NEWS FOR BENITEC GOOOOOOOO BENITEC



    Update on Nucleonics’ request to US Supreme Court
    10 January 2008, Melbourne, Australia: The Directors of Benitec Limited (ASX:BLT) provide the following update on its release last week regarding Nucleonics’ request that the US Supreme Court hear the Benitec v Nucleonics case.
    Benitec has now had the chance to consider and receive advice on the Nucleonics petition. The Nucleonics petition has not raised any legal issues not considered by the US Federal Circuit, which decided Benitec v Nucleonics in Benitec's favour. Benitec intends to file an opposition brief to the Supreme Court by 1 February 2008.
    Benitec believes that the Federal Circuit decision correctly followed recent Supreme Court decisions clarifying jurisdiction for declaratory judgment under Article III, and denial of the petition is appropriate. Benitec believes it is unlikely that the Supreme Court will hear this case given its recent Merck vs. Integra and MedImmune vs. Genentech rulings. Moreover, the Supreme Court rarely grants petitions for certiorari. In recent terms of the Supreme Court, petitioners have submitted more than 7,000 petitions for certiorari per term. Of these, approximately 100, or roughly 1.4%, are granted per term. When the Supreme Court grants a petition for certiorari, it will normally decide the case during the same term, but cases can be carried over to the next term.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.